Philip J. DiSaia

Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines

Kyle Ellrott, Matthew H. Bailey, Gordon Saksena et al. · Cell Systems · 2018 · 895 citations · Full text

Engineering, Genetics, Genomics +17

Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)

Krishnansu S. Tewari, Michael W. Sill, Richard T. Penson et al. · The Lancet · 2017 · 656 citations · Full text

Advanced Cervical Cancer, Cervical Cancer Management, Cervical Cancer +11

Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study.

Richard C. Boronow, C. Paul Morrow, William T. Creasman et al. · PubMed · 1984 · 593 citations

Surgical Oncology, Cancer Pathology, Gynecology +18

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer

Krishnansu S. Tewari, Robert A. Burger, Danielle Enserro et al. · Journal of Clinical Oncology · 2019 · 461 citations · Full text

Carcinoma of the cervix treated with radiation therapy I. A multi-variate analysis of prognostic variables in the gynecologic oncology group

Frederick B. Stehman, Brian N. Bundy, Philip J. DiSaia et al. · Cancer · 1991 · 435 citations · Full text